Phase II Trial to Validate Markers for a Response Evaluation of a Combined Therapy in Patients With HER2+ Breast Cancer
Clinical trial NCT01891357 · TERMINATED
Trial details
- NCT number
- NCT01891357
- Sponsor
- Women's Cancer Study Group GmbH
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-30
- Primary completion
- 2016-11-16
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.